Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
ILIllumina, Inc. logo

Illumina, Inc. (ILMN)

NASDAQ Global Select · Currency in USD
$269.42 ▲ +0.02 (+0.01%)
At close: Oct 23, 4:00 PM ET. Market closed.
$267.60 ▼ -1.82 (-0.68%)
After hours: Oct 23, 7:56 PM ET

Summary

Previous Close
$269.40
Open
$264.42
Day's Range
$264.42 – $271.64
52 Week Range
$94.00 – $309.35
Volume
1,262,918
Avg. Volume
2,533,348
Market Cap
$40.68B
Beta (5Y Monthly)
1.42
PE Ratio (TTM)
49.80
EPS (TTM)
$5.46
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$252.73

Profile: Illumina, Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
8,600
CEO
Jacob Thaysen

Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $1.36 · Revenue est. $1.15B
DateEst.Actual
Jul 30, 2026$1.23$1.31Beat
Apr 30, 2026$1.05$1.15Beat
Feb 5, 2026$1.24$1.35Beat
Oct 30, 2025$1.17$1.34Beat
Jul 31, 2025$1.02$1.19Beat
May 8, 2025$0.94$0.97Beat

Analyst view

Consensus price target
$252.73 ▼ -6.2%
Range $155.00 – $305.00
Rating: Buy
Buy 54% · Hold 34% · Sell 12%

Get free alerts on ILMN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.